NewLimit
StartupUSfounded 20211 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechDevelops epigenetic reprogramming medicines to restore youthful function in old cells, starting with the liver. | Develops epigenetic reprogramming medicines to restore youthful function in old cells, starting with the liver. | blog.newlimit.com |
Funding
| Date | Round | Amount | |
|---|---|---|---|
| Jun 2, 2026 | Series CLed by Founders Fund | $435M | blog.newlimit.com |
| Oct 20, 2025 | Extension | $45M | blog.newlimit.com |
| May 6, 2025 | Series BLed by Kleiner Perkins | $130M | blog.newlimit.com |
About
- Source
- blog.newlimit.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | NewLimitCompany in Longevity biotech: Joined a field, Develops epigenetic reprogramming medicines to restore youthful function in old cells, starting with the liver. | seed | blog.newlimit.com |
| Sep 25, 2026 | NewLimitCompany: Added | seed | blog.newlimit.com |